Federation Des Caisses Desjardins Du Quebec Logic Bio Therapeutics, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024
SELL
$0.0 - $2.07 $0 - $1,862
-900 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.61 - $2.49 $549 - $2,241
900 New
900 $612,000
Q2 2021

Aug 30, 2024
BUY
$4.03 - $7.57 $3,627 - $6,813
900 New
900 $4 Million
Q1 2021

Aug 30, 2024
BUY
$6.8 - $9.16 $6,120 - $8,244
900 New
900 $6.55 Million

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email